Overview

Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia

Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
Auxiliary drugs augment the effect of local anesthetic in intravenous regional anesthesia (IVRA). The purpose of our study was to estimate the median effective dose (ED50) of Dexmedetomidine in elective upper limb Lidocaine 0.5% IVRA.
Phase:
Phase 4
Details
Lead Sponsor:
South Valley University
Collaborator:
Tanta University
Treatments:
Anesthetics
Dexmedetomidine
Lidocaine